Side effects of anabolic-androgenic steroids abuse – empirical research based on anonymous surveys among people who regularly attend the gym
DOI:
https://doi.org/10.12775/QS.2023.14.01.008Keywords
anabolic-androgenic steroids, testosterone, doping, gym, bodybuildingAbstract
Introduction: The use of anabolic androgenic steroids is particularly common in regular gyms and fitness centres participants. AAS are usually synthetic derivatives of testosterone with anabolic and androgenic effect. However, many people, including AAS users, do not realize how many side effects they can cause.
The aim of the study: The aim of the study was to assess if people who regularly attend to the gym are aware of the side effects of using anabolic steroids by empirical research based on anonymous surveys.
Materials and methods: The research material was collected using an anonymous online survey in April 2023. The obtained results were analyzed and verified on the basis of scientific literature and statistically processed using Microsoft Office Excel.
Results: Of the 112 gym participants, 20,5% reported using anabolic-androgenic steroids in the past. Most of the people filling the questionnaire are aware of the negative health effects of AAS use. However, most of them can't name more than 4 side effects, which shows that knowledge about AAS is still unexplored by this social group.
Conclusion: The use of anabolic androgenic steroids to increase muscle size and strength is widespread. Various side effects are very common when using AAS, some of them can seriously affect the health of the users. By raising awareness of side-effects that AAS can cause, it is possible to discourage many people from using these performance-enhancing substances.
Keywords: Anabolic-androgenic steroids, testosterone, gym, doping, bodybuilding
References
Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014 May;24(5):383-98. doi: 10.1016/j.annepidem.2014.01.009. Epub 2014 Jan 30. PMID: 24582699.
Kuhn CM. Anabolic steroids. Recent Prog Horm Res. 2002;57:411-34. doi: 10.1210/rp.57.1.411. PMID: 12017555.
Woerdeman J, de Hon O, Levi M, de Ronde WP. Anabole androgene steroïden bij amateursporters in Nederland [Anabolic androgenic steroids in amateur sports in the Netherlands]. Ned Tijdschr Geneeskd. 2010;154:A2004. Dutch. PMID: 20858322.
Heuberger JAAC, Cohen AF. Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects. Sports Med. 2019 Apr;49(4):525-539. doi: 10.1007/s40279-018-1014-1. PMID: 30411235; PMCID: PMC6422964.
Kalicharan RW, Baron P, Oussoren C, Bartels LW, Vromans H. Spatial distribution of oil depots monitored in human muscle using MRI. Int J Pharm. 2016 May 30;505(1-2):52-60. doi: 10.1016/j.ijpharm.2016.03.064. Epub 2016 Mar 31. PMID: 27041126.
Täuber U, Schröder K, Düsterberg B, Matthes H. Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone. Eur J Drug Metab Pharmacokinet. 1986 Apr-Jun;11(2):145-9. doi: 10.1007/BF03189840. PMID: 3770015.
Albano GD, Amico F, Cocimano G, Liberto A, Maglietta F, Esposito M, Rosi GL, Di Nunno N, Salerno M, Montana A. Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review. Healthcare (Basel). 2021 Jan 19;9(1):97. doi: 10.3390/healthcare9010097. PMID: 33477800; PMCID: PMC7832337.
Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513-54. doi: 10.2165/00007256-200434080-00003. PMID: 15248788.
Adachi M, Takayanagi R. [Effect of anabolic steroids on osteoporosis]. Clin Calcium. 2008 Oct;18(10):1451-9. Japanese. PMID: 18830042.
Shimoda K, Shide K, Kamezaki K, Okamura T, Harada N, Kinukawa N, Ohyashiki K, Niho Y, Mizoguchi H, Omine M, Ozawa K, Haradaa M. The effect of anabolic steroids on anemia in myelofibrosis with myeloid metaplasia: retrospective analysis of 39 patients in Japan. Int J Hematol. 2007 May;85(4):338-43. doi: 10.1532/IJH97.06135. PMID: 17483079.
Abrams D. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy. AIDS Read. 2001 Mar;11(3):149-56. PMID: 17004352.
Foster ZJ, Housner JA. Anabolic-androgenic steroids and testosterone precursors: ergogenic aids and sport. Curr Sports Med Rep. 2004 Aug;3(4):234-41. doi: 10.1249/00149619-200408000-00011. PMID: 15231229.
Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. Am J Sports Med. 1984 Nov-Dec;12(6):469-84. doi: 10.1177/036354658401200613. PMID: 6391216.
Ip EJ, Yadao MA, Shah BM, Lau B. Infectious disease, injection practices, and risky sexual behavior among anabolic steroid users. AIDS Care. 2016;28(3):294-9. doi: 10.1080/09540121.2015.1090539. Epub 2015 Sep 30. PMID: 26422090.
Pai R, Parampalli U, Hettiarachchi G, Ahmed I. Mycobacterium fortuitum skin infection as a complication of anabolic steroids: a rare case report. Ann R Coll Surg Engl. 2013 Jan;95(1):e12-3. doi: 10.1308/rcsann.2013.95.5.e12a. PMID: 23317715; PMCID: PMC3964671.
Määttä J. Stretch Mark Treatment by Tattooing and Microneedling. Curr Probl Dermatol. 2022;56:205-211. doi: 10.1159/000529556. Epub 2023 Jun 1. PMID: 37263224.
Liu JD, Wu YQ. Anabolic-androgenic steroids and cardiovascular risk. Chin Med J (Engl). 2019 Sep 20;132(18):2229-2236. doi: 10.1097/CM9.0000000000000407. PMID: 31478927; PMCID: PMC6797160.
Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG Jr. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction. 2015 May;110(5):823-31. doi: 10.1111/add.12850. Epub 2015 Feb 25. PMID: 25598171; PMCID: PMC4398624.
Brower KJ. Anabolic steroid abuse and dependence. Curr Psychiatry Rep. 2002 Oct;4(5):377-87. doi: 10.1007/s11920-002-0086-6. PMID: 12230967.
Morrison TR, Ricci LA, Puckett AS, Joyce J, Curran R, Davis C, Melloni RH Jr. Serotonin type-3 receptors differentially modulate anxiety and aggression during withdrawal from adolescent anabolic steroid exposure. Horm Behav. 2020 Mar;119:104650. doi: 10.1016/j.yhbeh.2019.104650. Epub 2019 Dec 15. PMID: 31805280.
Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009 Dec;104(12):1966-78. doi: 10.1111/j.1360-0443.2009.02734.x. PMID: 19922565; PMCID: PMC2780436.
Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P, Sani G. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review. Curr Neuropharmacol. 2015 Jan;13(1):101-21. doi: 10.2174/1570159X13666141210222725. PMID: 26074746; PMCID: PMC4462035.
Hauger LE, Westlye LT, Bjørnebekk A. Anabolic androgenic steroid dependence is associated with executive dysfunction. Drug Alcohol Depend. 2020 Mar 1;208:107874. doi: 10.1016/j.drugalcdep.2020.107874. Epub 2020 Jan 17. PMID: 31972519.
Hauger LE, Sagoe D, Vaskinn A, Arnevik EA, Leknes S, Jørstad ML, Bjørnebekk A. Anabolic androgenic steroid dependence is associated with impaired emotion recognition. Psychopharmacology (Berl). 2019 Sep;236(9):2667-2676. doi: 10.1007/s00213-019-05239-7. Epub 2019 Apr 2. PMID: 30941469.
Melchert RB, Welder AA. Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc. 1995 Sep;27(9):1252-62. PMID: 8531623.
Pärssinen M, Seppälä T. Steroid use and long-term health risks in former athletes. Sports Med. 2002;32(2):83-94. doi: 10.2165/00007256-200232020-00001. PMID: 11817994.
Pärssinen M, Kujala U, Vartiainen E, Sarna S, Seppälä T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med. 2000 Apr;21(3):225-7. doi: 10.1055/s-2000-304. PMID: 10834358.
Smit DL, Buijs MM, de Hon O, den Heijer M, de Ronde W. Positive and negative side effects of androgen abuse. The HAARLEM study: A one-year prospective cohort study in 100 men. Scand J Med Sci Sports. 2021 Feb;31(2):427-438. doi: 10.1111/sms.13843. Epub 2020 Nov 4. PMID: 33038020.
Eklöf AC, Thurelius AM, Garle M, Rane A, Sjöqvist F. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol. 2003 Nov;59(8-9):571-7. doi: 10.1007/s00228-003-0633-z. Epub 2003 Sep 12. PMID: 13680032.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Monika Pająk, Kinga Grużewska-Piotrowska, Joanna Hubka, Agnieszka Grużewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 990
Number of citations: 0